AVBP · ArriVent BioPharma, Inc.
$28.22
-4.97 (-14.97%)
At close · Jul 20
Market Cap
$1.32B
Shares
46.57M
Total shares sold short and not yet covered, reported to FINRA by broker-dealers and published twice a month (bi-monthly). Days to cover divides the short position by average daily volume; a high value (above 5) can signal short-squeeze potential.
Short Squeeze Score
65/100
Short interest 16.4% of shares — P96
Days to cover 9.1 — P94
Price vs VWAP -9.6% — P30
Short-volume trend -31.9% — P3
Short interest change -2.8% — P37
Worst FTD 0.29% of shares — P86
Peer-relative percentile rank across all stocks reporting short interest at the latest settlement date (2026-06-30). Weighted mean of the available factors (short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, fails-to-deliver 10%) plus catalyst boosts (price spike, volume surge, earnings within days), capped at +20 and clamped to 100.
Short Interest History
| Settlement Date | Current Position | Previous Position | Change | Days to Cover |
|---|---|---|---|---|
| 2026-06-30 | 7,624,281 | 7,847,671 | -223,390 | 9.05 |
| 2026-06-15 | 7,847,671 | 7,709,676 | +137,995 | 13.12 |
| 2026-05-29 | 7,709,676 | 7,299,894 | +409,782 | 14.42 |
| 2026-05-15 | 7,299,894 | 7,109,751 | +190,143 | 22.55 |
| 2026-04-30 | 7,109,751 | 7,666,061 | -556,310 | 14.30 |
| 2026-04-15 | 7,666,061 | 7,763,960 | -97,899 | 14.54 |
| 2026-03-31 | 7,763,960 | 7,228,395 | +535,565 | 17.89 |
| 2026-03-13 | 7,228,395 | 7,003,796 | +224,599 | 9.33 |
| 2026-02-27 | 7,003,796 | 7,046,765 | -42,969 | 25.09 |
| 2026-02-13 | 7,046,765 | 7,216,603 | -169,838 | 11.53 |
| 2026-01-30 | 7,216,603 | 7,178,615 | +37,988 | 16.70 |
| 2026-01-15 | 7,178,615 | 6,985,261 | +193,354 | 18.17 |
| 2025-12-31 | 6,985,261 | 6,747,370 | +237,891 | 14.91 |
| 2025-12-15 | 6,747,370 | 7,262,061 | -514,691 | 14.76 |
| 2025-11-28 | 7,262,061 | 7,169,047 | +93,014 | 28.67 |
| 2025-11-14 | 7,169,047 | 6,927,026 | +242,021 | 19.44 |
| 2025-10-31 | 6,927,026 | 7,063,874 | -136,848 | 22.65 |
| 2025-10-15 | 7,063,874 | 6,783,254 | +280,620 | 23.57 |
| 2025-09-30 | 6,783,254 | 6,594,695 | +188,559 | 17.09 |
| 2025-09-15 | 6,594,695 | 6,797,763 | -203,068 | 19.30 |
| 2025-08-29 | 6,797,763 | 6,701,282 | +96,481 | 34.54 |
| 2025-08-15 | 6,701,282 | 6,091,463 | +609,819 | 19.23 |
| 2025-07-31 | 6,091,463 | 5,798,215 | +293,248 | 24.12 |
Showing 1–23 of 23 settlements
Key facts
CIK
1868279
CUSIP
04272N102
13F (30d)
11 filings
11 filers
Visit website
Investor relations